Welcome to LookChem.com Sign In|Join Free

CAS

  • or

628-77-3

Post Buying Request

628-77-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

628-77-3 Usage

Uses

1,5-Diiodopentane is used as a crosslinking reagent. It is used in the preparation of (iodoalkylaminocarbene)tungsten complexes. It is also used as alkylation to form unsubstituted cyclohexane. It is involved in the preparation of poly(1-vinyl imidazole-co-elthylene glycol methyl ether acrylate electrolytes and used for quasi-solid state dye-sensitized solar cells.

General Description

Electrochemical reduction of 1,5-diiodopentane at carbon electrodes in DMF containing tetramethylammonium perchlorate has been studied by cyclic voltammetry and controlled-potential electrolysis.

Safety Profile

Mutation data reported. When heated to decomposition it emits toxic vapors of Ií.

Check Digit Verification of cas no

The CAS Registry Mumber 628-77-3 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 6,2 and 8 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 628-77:
(5*6)+(4*2)+(3*8)+(2*7)+(1*7)=83
83 % 10 = 3
So 628-77-3 is a valid CAS Registry Number.
InChI:InChI=1/C5H10I2/c6-4-2-1-3-5-7/h1-5H2

628-77-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A17298)  1,5-Diiodopentane, 97%, stab. with copper   

  • 628-77-3

  • 25g

  • 421.0CNY

  • Detail
  • Alfa Aesar

  • (A17298)  1,5-Diiodopentane, 97%, stab. with copper   

  • 628-77-3

  • 100g

  • 1535.0CNY

  • Detail
  • Aldrich

  • (252131)  1,5-Diiodopentane  97%, contains copper as stabilizer

  • 628-77-3

  • 252131-25G

  • 1,173.51CNY

  • Detail
  • Aldrich

  • (252131)  1,5-Diiodopentane  97%, contains copper as stabilizer

  • 628-77-3

  • 252131-100G

  • 3,614.13CNY

  • Detail

628-77-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 1,5-Diiodopentane

1.2 Other means of identification

Product number -
Other names diiodopentane

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:628-77-3 SDS

628-77-3Synthetic route

1 ,5-pentanediol
111-29-5

1 ,5-pentanediol

1,5-diiodopentane
628-77-3

1,5-diiodopentane

Conditions
ConditionsYield
With iodine In dichloromethane at 20℃; for 1h; Temperature; Solvent;95%
With trimethylsilylphosphate; sodium iodide for 10h; Ambient temperature;92%
With phosphorus; iodine
(i) P2I4, CS2, (ii) K2CO3; Multistep reaction;
{η5-(C5H5)Ru(CO)2}{μ-(CH2)5}

{η5-(C5H5)Ru(CO)2}{μ-(CH2)5}

A

iodo(cyclopentadienyl)dicarbonylruthenium(II)

iodo(cyclopentadienyl)dicarbonylruthenium(II)

B

1,5-diiodopentane
628-77-3

1,5-diiodopentane

Conditions
ConditionsYield
With iodine In tetrahydrofuran under N2, stirred at room temp. for 10 min; solvent removed under reduced pressure, residue dissolved (CH2Cl2), chromy. (alumina, hexane, CH2Cl2);A 86%
B >90
TETRAHYDROPYRANE
142-68-7

TETRAHYDROPYRANE

1,5-diiodopentane
628-77-3

1,5-diiodopentane

Conditions
ConditionsYield
With O-phenyl phosphorodichloridate; sodium iodide for 24h; Heating;83%
With N,N-diethyl-1,1,1-trimethylsilanamine; methyl iodide In toluene at 80 - 90℃; for 48h; Ring cleavage; iodination; diiodation; diiodination;33%
With boron trifluoride diethyl etherate; sodium iodide Reflux; Green chemistry;30%
With water; hydrogen iodide
With trimethylsilyl iodide
TETRAHYDROPYRANE
142-68-7

TETRAHYDROPYRANE

triiododipropylphosphorane

triiododipropylphosphorane

A

1,5-diiodopentane
628-77-3

1,5-diiodopentane

B

(5-iodopentyl) dipropylphosphinate

(5-iodopentyl) dipropylphosphinate

Conditions
ConditionsYield
for 16h; Heating;A n/a
B 80%
1 ,5-pentanediol
111-29-5

1 ,5-pentanediol

A

1,5-diiodopentane
628-77-3

1,5-diiodopentane

B

5-iodo-1-pentanol
67133-88-4

5-iodo-1-pentanol

C

C10H21I2O3P

C10H21I2O3P

Conditions
ConditionsYield
With diphosphorous tetraiodide In carbon disulfide for 4h; Ambient temperature;A 25%
B 50%
C 2%
1,1-bis-(1,1,2-trimethyl-allylperoxy)-cyclohexane

1,1-bis-(1,1,2-trimethyl-allylperoxy)-cyclohexane

1,5-diiodopentane
628-77-3

1,5-diiodopentane

Conditions
ConditionsYield
With triethyl borane; oxygen; ethyl iodoacetae In hexane; cyclohexane Ambient temperature;40%
1,5-dibromo-pentane
111-24-0

1,5-dibromo-pentane

1,5-diiodopentane
628-77-3

1,5-diiodopentane

Conditions
ConditionsYield
With acetone; sodium iodide
With methanol; sodium iodide
With sodium iodide In N,N-dimethyl-formamide for 0.333333h; Heating;
1,5-dichloropentane
628-76-2

1,5-dichloropentane

1,5-diiodopentane
628-77-3

1,5-diiodopentane

Conditions
ConditionsYield
With acetone; sodium iodide
1,5-diphenoxypentane
40339-96-6

1,5-diphenoxypentane

1,5-diiodopentane
628-77-3

1,5-diiodopentane

Conditions
ConditionsYield
With hydrogen iodide at 130 - 140℃;
2-methoxytetrahydropyran
6581-66-4

2-methoxytetrahydropyran

1,5-diiodopentane
628-77-3

1,5-diiodopentane

Conditions
ConditionsYield
With diiodosilane In chloroform-d1 for 12h; Ambient temperature; 3 equiv DIS;100 % Spectr.
pentane-1,5-diyl dimethanesulfonate
2374-22-3

pentane-1,5-diyl dimethanesulfonate

1,5-diiodopentane
628-77-3

1,5-diiodopentane

Conditions
ConditionsYield
With sodium iodide In acetone at 70℃; for 0.333333h;
1,5-dibromo-pentane
111-24-0

1,5-dibromo-pentane

acetone
67-64-1

acetone

sodium iodide

sodium iodide

1,5-diiodopentane
628-77-3

1,5-diiodopentane

1,5-dichloropentane
628-76-2

1,5-dichloropentane

acetone
67-64-1

acetone

sodium iodide

sodium iodide

A

1,5-diiodopentane
628-77-3

1,5-diiodopentane

B

1-chloro-5-iodopentane
60274-60-4

1-chloro-5-iodopentane

1,5-diphenoxypentane
40339-96-6

1,5-diphenoxypentane

hydrogen iodide
10034-85-2

hydrogen iodide

1,5-diiodopentane
628-77-3

1,5-diiodopentane

Conditions
ConditionsYield
at 130 - 140℃;
iodine
7553-56-2

iodine

pentanediyldimercury (2+); iodide

pentanediyldimercury (2+); iodide

benzene
71-43-2

benzene

A

1,5-diiodopentane
628-77-3

1,5-diiodopentane

B

HgI2

HgI2

Hg,Hg'-diphenyl-Hg,Hg'-pentanediyl-di-mercury
859950-14-4

Hg,Hg'-diphenyl-Hg,Hg'-pentanediyl-di-mercury

iodine
7553-56-2

iodine

benzene
71-43-2

benzene

A

iodobenzene
591-50-4

iodobenzene

B

1,5-diiodopentane
628-77-3

1,5-diiodopentane

C

mercury iodide

mercury iodide

Conditions
ConditionsYield
bei laengerem Kochen;
1 ,5-pentanediol
111-29-5

1 ,5-pentanediol

tetraacetyl silicate

tetraacetyl silicate

1,5-diiodopentane
628-77-3

1,5-diiodopentane

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 9 percent / pyridine; CH2Cl2 / 25 °C
2: NaI / acetone / 0.33 h / 70 °C
View Scheme
1,5-pentanedioic acid
110-94-1

1,5-pentanedioic acid

1,5-diiodopentane
628-77-3

1,5-diiodopentane

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: concentrated sulfuric acid
2: sodium; alcohol
3: red phosphorus; iodine
View Scheme
Diethyl glutarate
818-38-2

Diethyl glutarate

1,5-diiodopentane
628-77-3

1,5-diiodopentane

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium; alcohol
2: red phosphorus; iodine
View Scheme
1-bromo-5-chloropentane
54512-75-3

1-bromo-5-chloropentane

(R)-7-methylnonyl chloride
1224161-11-8

(R)-7-methylnonyl chloride

A

1,5-diiodopentane
628-77-3

1,5-diiodopentane

B

(R)-7-methylnonyl iodide
1224161-12-9

(R)-7-methylnonyl iodide

Conditions
ConditionsYield
With sodium iodide In N,N-dimethyl-formamide for 10h; Reflux;
1,5-diiodopentane
628-77-3

1,5-diiodopentane

(S,E)-(2-(((tert-butyldimethylsilyl)oxy)methyl)-4-ethylidenepyrrolidin-1-yl)(4-hydroxy-5methoxy-2-nitrophenyl)methanone

(S,E)-(2-(((tert-butyldimethylsilyl)oxy)methyl)-4-ethylidenepyrrolidin-1-yl)(4-hydroxy-5methoxy-2-nitrophenyl)methanone

((pentane-1,5-diylbis(oxy))bis(5-methoxy-2-nitro-4,1-phenylene))bis(((S,E)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-ethylidenepyrrolidin-1-yl)methanone)

((pentane-1,5-diylbis(oxy))bis(5-methoxy-2-nitro-4,1-phenylene))bis(((S,E)-2-(((tert-butyldimethylsilyl)oxy)methyl)-4-ethylidenepyrrolidin-1-yl)methanone)

Conditions
ConditionsYield
With tetra-(n-butyl)ammonium iodide; potassium carbonate In acetone at 45 - 60℃;100%
1,5-diiodopentane
628-77-3

1,5-diiodopentane

(1R,2S)-norephedrine
492-41-1

(1R,2S)-norephedrine

(1R,2S)-1-phenyl-2-piperidinopropanol
133576-76-8

(1R,2S)-1-phenyl-2-piperidinopropanol

Conditions
ConditionsYield
With potassium carbonate In ethanol99%
1,5-diiodopentane
628-77-3

1,5-diiodopentane

(4-bromo-phenyl)-acetic acid methyl ester
41841-16-1

(4-bromo-phenyl)-acetic acid methyl ester

methyl 1-(4-bromophenyl)cyclohexanecarboxylate
1236357-63-3

methyl 1-(4-bromophenyl)cyclohexanecarboxylate

Conditions
ConditionsYield
Stage #1: (4-bromo-phenyl)-acetic acid methyl ester With sodium hydride In tetrahydrofuran at 35℃; for 2h; Inert atmosphere;
Stage #2: 1,5-diiodopentane In tetrahydrofuran at 20 - 35℃; Inert atmosphere;
99%
Stage #1: (4-bromo-phenyl)-acetic acid methyl ester With sodium hydride In tetrahydrofuran; mineral oil at 35℃; for 2h; Inert atmosphere;
Stage #2: 1,5-diiodopentane In tetrahydrofuran; mineral oil at 20 - 35℃;
99%
(11S,11aS)-8-hydroxy-10-(tert-butyloxycarbonyl)-7-methoxy-11-(tetrahydropyran-2-yloxy)-1,2,3,10,11,11a-hexahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one
864665-57-6

(11S,11aS)-8-hydroxy-10-(tert-butyloxycarbonyl)-7-methoxy-11-(tetrahydropyran-2-yloxy)-1,2,3,10,11,11a-hexahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one

1,5-diiodopentane
628-77-3

1,5-diiodopentane

1,1'-[(pentane-1,5-diyl)dioxy]bis[(11S,11aS)-10-(tert-butyloxycarbonyl)-7-methoxy-11-(tetrahydropyran-2-yloxy)-1,2,3,10,11,11a-hexahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one]
864665-63-4

1,1'-[(pentane-1,5-diyl)dioxy]bis[(11S,11aS)-10-(tert-butyloxycarbonyl)-7-methoxy-11-(tetrahydropyran-2-yloxy)-1,2,3,10,11,11a-hexahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one]

Conditions
ConditionsYield
With potassium carbonate In DMF (N,N-dimethyl-formamide) at 90℃; for 5h;98%
1,5-diiodopentane
628-77-3

1,5-diiodopentane

ACC-d2 methyl ester
119111-72-7

ACC-d2 methyl ester

methyl cis-2,3-dideuterio-1-(1-piperidino)cyclopropanecarboxylate
119111-73-8

methyl cis-2,3-dideuterio-1-(1-piperidino)cyclopropanecarboxylate

Conditions
ConditionsYield
With tetrabutylammomium bromide; potassium carbonate In acetonitrile for 36h; Heating;97%
1,5-diiodopentane
628-77-3

1,5-diiodopentane

methylmagnesium bromide
75-16-1

methylmagnesium bromide

methyl (2S)-2-amino-3-phenylpropanoate hydrochloride
7524-50-7

methyl (2S)-2-amino-3-phenylpropanoate hydrochloride

(S)-2-methyl-4-phenyl-3-(piperidin-1-yl)butan-2-ol

(S)-2-methyl-4-phenyl-3-(piperidin-1-yl)butan-2-ol

Conditions
ConditionsYield
Stage #1: methylmagnesium bromide; methyl (2S)-2-amino-3-phenylpropanoate hydrochloride In tetrahydrofuran at 20℃; for 12h;
Stage #2: 1,5-diiodopentane With potassium carbonate In tetrahydrofuran; acetonitrile for 24h; Heating;
97%
chloropyridinecobaloxime(III)

chloropyridinecobaloxime(III)

1,5-diiodopentane
628-77-3

1,5-diiodopentane

Co(HONC(CH3)C(CH3)NO)2(C5H5N)((CH2)5I)
186552-73-8

Co(HONC(CH3)C(CH3)NO)2(C5H5N)((CH2)5I)

Conditions
ConditionsYield
With sodium tetrahydroborate In methanol N2-atmosphere; stirring Co-complex with 2 equiv. of diiodide for 5 min, addn. of excess NaBH4, stirring for 12 min; in air; crystn. (0°C), filtration, washing (cold MeOH), addn. of H2O to filtrate, crystn. (-15°C, 12 h), recrystn. of combined portions (CH2Cl2/hexane); elem. anal.;95%
pyridine
110-86-1

pyridine

1,5-diiodopentane
628-77-3

1,5-diiodopentane

[1,1′-(pentane-1,5-diyl)bispyridinium diiodide]

[1,1′-(pentane-1,5-diyl)bispyridinium diiodide]

Conditions
ConditionsYield
In acetonitrile Reflux;94%
at 65℃; for 24h;90%
at 65℃; for 24h;
for 120 - 168h; Reflux;
1,5-diiodopentane
628-77-3

1,5-diiodopentane

methyl (2S)-2-amino-3-phenylpropanoate hydrochloride
7524-50-7

methyl (2S)-2-amino-3-phenylpropanoate hydrochloride

(S)-3-phenyl-2-(piperidin-1-yl)-propan-1-ol

(S)-3-phenyl-2-(piperidin-1-yl)-propan-1-ol

Conditions
ConditionsYield
Stage #1: methyl (2S)-2-amino-3-phenylpropanoate hydrochloride In tetrahydrofuran at 20℃; for 12h; hydride reduction;
Stage #2: 1,5-diiodopentane With potassium carbonate In tetrahydrofuran; acetonitrile for 24h; Heating;
93%
1,5-diiodopentane
628-77-3

1,5-diiodopentane

ethylmagnesium bromide
925-90-6

ethylmagnesium bromide

L-valine methylester hydrochloride
6306-52-1

L-valine methylester hydrochloride

(S)-3-ethyl-5-methyl-4-(piperidin-1-yl)hexan-3-ol

(S)-3-ethyl-5-methyl-4-(piperidin-1-yl)hexan-3-ol

Conditions
ConditionsYield
Stage #1: ethylmagnesium bromide; L-valine methylester hydrochloride In tetrahydrofuran at 20℃; for 12h;
Stage #2: 1,5-diiodopentane With potassium carbonate In tetrahydrofuran; acetonitrile for 24h; Heating;
92%
1,5-diiodopentane
628-77-3

1,5-diiodopentane

ethylmagnesium bromide
925-90-6

ethylmagnesium bromide

methyl (2S)-2-amino-3-phenylpropanoate hydrochloride
7524-50-7

methyl (2S)-2-amino-3-phenylpropanoate hydrochloride

(S)-3-ethyl-1-phenyl-2-(piperidin-1-yl)pentan-3-ol

(S)-3-ethyl-1-phenyl-2-(piperidin-1-yl)pentan-3-ol

Conditions
ConditionsYield
Stage #1: ethylmagnesium bromide; methyl (2S)-2-amino-3-phenylpropanoate hydrochloride In tetrahydrofuran at 20℃; for 12h;
Stage #2: 1,5-diiodopentane With potassium carbonate In tetrahydrofuran; acetonitrile for 24h; Heating;
92%
1,5-diiodopentane
628-77-3

1,5-diiodopentane

(S)-allyl (3-hydroxy-2-methoxy-6,14-dioxo-5-((2-(trimethylsilyl)ethoxy)methyl)-5,6,6a,7,12,14-hexahydrobenzo[5,6][1,4]diazepino[1,2-b]isoquinolin-10-yl)carbamate

(S)-allyl (3-hydroxy-2-methoxy-6,14-dioxo-5-((2-(trimethylsilyl)ethoxy)methyl)-5,6,6a,7,12,14-hexahydrobenzo[5,6][1,4]diazepino[1,2-b]isoquinolin-10-yl)carbamate

C61H78N6O14Si2

C61H78N6O14Si2

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 6h;92%
N,N
72814-05-2

N,N"-dimethyl-1,7,10,16-tetraoxa-4,13-diaza-(16)orthocyclophan

1,5-diiodopentane
628-77-3

1,5-diiodopentane

C23H40N2O4(2+)*2I(1-)
97421-98-2

C23H40N2O4(2+)*2I(1-)

Conditions
ConditionsYield
In acetone at 25℃; under 10000 Torr; for 20h;91%
1,5-diiodopentane
628-77-3

1,5-diiodopentane

(hydridotris-(3,5-dimethylpyrazoyl)borate)(CO)(I)W(HCCCH3)

(hydridotris-(3,5-dimethylpyrazoyl)borate)(CO)(I)W(HCCCH3)

(hydridotris-(3,5-dimethylpyrazoyl)borate)(CO)(I)W(H3CCC(CH2)5I)

(hydridotris-(3,5-dimethylpyrazoyl)borate)(CO)(I)W(H3CCC(CH2)5I)

Conditions
ConditionsYield
With BuLi In tetrahydrofuran N2-atmosphere; stirring (room temp., 1 h); evapn., chromy. (alumina, hexane / CH2Cl2), crystn. (CH2Cl2 / pentane); elem. anal.;91%
1,5-diiodopentane
628-77-3

1,5-diiodopentane

(4S,5R)-3-tert-Butoxycarbonyl-4-cyclohexyl-methyl-2,2-dimethyloxazolidine-5-carboxylic acid
121533-54-8

(4S,5R)-3-tert-Butoxycarbonyl-4-cyclohexyl-methyl-2,2-dimethyloxazolidine-5-carboxylic acid

(4S,5R)-4-Cyclohexylmethyl-2,2-dimethyl-oxazolidine-3,5-dicarboxylic acid 3-tert-butyl ester 5-(5-iodo-pentyl) ester
155381-82-1

(4S,5R)-4-Cyclohexylmethyl-2,2-dimethyl-oxazolidine-3,5-dicarboxylic acid 3-tert-butyl ester 5-(5-iodo-pentyl) ester

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide for 2h; Ambient temperature;90%
1,5-diiodopentane
628-77-3

1,5-diiodopentane

bromure de triphenyl aminophosphonium
15931-69-8

bromure de triphenyl aminophosphonium

1-piperidino-triphenylphosphonium iodide

1-piperidino-triphenylphosphonium iodide

Conditions
ConditionsYield
Stage #1: bromure de triphenyl aminophosphonium With n-butyllithium In tetrahydrofuran; hexane at -10℃; for 0.75h; Metallation;
Stage #2: 1,5-diiodopentane In tetrahydrofuran; hexane at 65℃; for 23h; Alkylation;
90%
1,5-diiodopentane
628-77-3

1,5-diiodopentane

Methyl 2-amino-4,6-O-benzylidene-2-deoxy-β-D-glucopyranoside
99745-44-5

Methyl 2-amino-4,6-O-benzylidene-2-deoxy-β-D-glucopyranoside

methyl 4,6-O-benzylidene-2-deoxy-2-(1-piperidinyl)-β-D-glucopyranoside

methyl 4,6-O-benzylidene-2-deoxy-2-(1-piperidinyl)-β-D-glucopyranoside

Conditions
ConditionsYield
With potassium carbonate In acetonitrile for 35h; Heating;90%
1,5-diiodopentane
628-77-3

1,5-diiodopentane

(11S,11aS)-allyl 11-((tert-butyldimethylsilyl)oxy)-8-hydroxy-7-methoxy-2-methyl-5-oxo-11,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-10(5H)-carboxylate
1430738-28-5

(11S,11aS)-allyl 11-((tert-butyldimethylsilyl)oxy)-8-hydroxy-7-methoxy-2-methyl-5-oxo-11,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-10(5H)-carboxylate

(11S,11aS)-allyl 11-((tert-butyldimethylsilyl)oxy)-8-((5-iodopentyl)oxy)-7-methoxy-2-methyl-5-oxo-11,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-10(5H)-carboxylate
1430738-29-6

(11S,11aS)-allyl 11-((tert-butyldimethylsilyl)oxy)-8-((5-iodopentyl)oxy)-7-methoxy-2-methyl-5-oxo-11,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-10(5H)-carboxylate

Conditions
ConditionsYield
With potassium carbonate at 60℃; for 6h;90%
With potassium carbonate In acetone at 60℃; for 6h; Molecular sieve;90%
With potassium carbonate In acetone at 60℃; for 6h;90%
1,5-diiodopentane
628-77-3

1,5-diiodopentane

7,13-dimethyl-7,13-diaza-1,4,10-trioxacyclopentadecane
58688-38-3

7,13-dimethyl-7,13-diaza-1,4,10-trioxacyclopentadecane

C17H36N2O3(2+)*2I(1-)
97421-87-9

C17H36N2O3(2+)*2I(1-)

Conditions
ConditionsYield
In acetone at 25℃; under 10000 Torr; for 20h;89%
1,5-diiodopentane
628-77-3

1,5-diiodopentane

β-naphthol
135-19-3

β-naphthol

5-(1-iodopentyl)-β-naphthol
940281-79-8

5-(1-iodopentyl)-β-naphthol

Conditions
ConditionsYield
With potassium carbonate In acetone for 27h; Heating;89%
1,5-diiodopentane
628-77-3

1,5-diiodopentane

3-(2-aminophenyl)-4-methyl-1,3-thiazole-2(3H)-thione
879283-39-3, 879283-40-6, 215809-07-7

3-(2-aminophenyl)-4-methyl-1,3-thiazole-2(3H)-thione

2,2'-(pentane-1,5-diyldi(sulfanediyl))bis[3-(2-aminophenyl)-4-methyl-1,3-thiazol-3-ium] diiodide

2,2'-(pentane-1,5-diyldi(sulfanediyl))bis[3-(2-aminophenyl)-4-methyl-1,3-thiazol-3-ium] diiodide

Conditions
ConditionsYield
In chloroform for 48h; Reflux;89%
1,5-diiodopentane
628-77-3

1,5-diiodopentane

1-ethoxyacetylene
927-80-0

1-ethoxyacetylene

7-iodo-1-ethoxyheptyne
1263190-89-1

7-iodo-1-ethoxyheptyne

Conditions
ConditionsYield
Stage #1: 1-ethoxyacetylene With n-butyllithium In tetrahydrofuran; hexanes at -78℃; for 1h; Inert atmosphere;
Stage #2: With N,N,N,N,N,N-hexamethylphosphoric triamide In tetrahydrofuran; hexanes at -78℃;
Stage #3: 1,5-diiodopentane In tetrahydrofuran; hexanes at -78 - 45℃;
89%
1,5-diiodopentane
628-77-3

1,5-diiodopentane

2-[(1R,2R)-2-amino-1,2-diphenylethyl]-2,3-dihydro-1H-isoindole-1,3-dione
1387581-28-3

2-[(1R,2R)-2-amino-1,2-diphenylethyl]-2,3-dihydro-1H-isoindole-1,3-dione

2-[(1R,2R)-1,2-Diphenyl-2-(piperidin-1-yl)ethyl]-2,3-dihydro-1H-isoindole-1,3-dione
1558718-40-3

2-[(1R,2R)-1,2-Diphenyl-2-(piperidin-1-yl)ethyl]-2,3-dihydro-1H-isoindole-1,3-dione

Conditions
ConditionsYield
With potassium carbonate In acetonitrile Reflux; Inert atmosphere;89%
trans-4-(tert-butoxycarbonylamino)cyclohexylamine

trans-4-(tert-butoxycarbonylamino)cyclohexylamine

1,5-diiodopentane
628-77-3

1,5-diiodopentane

tert-butyl (trans-4-(piperidin-1-yl)cyclohexyl)carbamate

tert-butyl (trans-4-(piperidin-1-yl)cyclohexyl)carbamate

Conditions
ConditionsYield
With potassium carbonate In acetonitrile at 70℃; for 2h;88.6%
1,5-diiodopentane
628-77-3

1,5-diiodopentane

ethylmagnesium bromide
925-90-6

ethylmagnesium bromide

(S)-methyl 2-amino-3-methylpentanoate hydrochloride
18598-74-8

(S)-methyl 2-amino-3-methylpentanoate hydrochloride

(4S)-3-ethyl-5-methyl-4-(piperidin-1-yl)heptan-3-ol

(4S)-3-ethyl-5-methyl-4-(piperidin-1-yl)heptan-3-ol

Conditions
ConditionsYield
Stage #1: ethylmagnesium bromide; (S)-methyl 2-amino-3-methylpentanoate hydrochloride In tetrahydrofuran at 20℃; for 12h;
Stage #2: 1,5-diiodopentane With potassium carbonate In tetrahydrofuran; acetonitrile for 24h; Heating;
88%
1,5-diiodopentane
628-77-3

1,5-diiodopentane

tert-butyl (11S,11aS)-11-((tert-butyldimethylsilyl)oxy)-7-methoxy-2-methylene-5-oxo-8-((triisopropylsilyl)oxy)-2,3,1 1,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-10(5H)-carboxylate

tert-butyl (11S,11aS)-11-((tert-butyldimethylsilyl)oxy)-7-methoxy-2-methylene-5-oxo-8-((triisopropylsilyl)oxy)-2,3,1 1,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-10(5H)-carboxylate

tert-butyl (11S,11aS)-8-((5-iodopentyl)oxy)-7-methoxy-2-methylene-5-oxo-11-((tetrahydro-2H-pyran-2-yl)oxy)-2, 3,11,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-10(5H)-carboxylate

tert-butyl (11S,11aS)-8-((5-iodopentyl)oxy)-7-methoxy-2-methylene-5-oxo-11-((tetrahydro-2H-pyran-2-yl)oxy)-2, 3,11,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-10(5H)-carboxylate

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 60℃;88%
3-(4-hydroxyphenyl)-thiazolidine-2,4-dione
24044-44-8

3-(4-hydroxyphenyl)-thiazolidine-2,4-dione

1,5-diiodopentane
628-77-3

1,5-diiodopentane

3-(4-(5-iodopentyloxy)phenyl)thiazolidine-2,4-dione

3-(4-(5-iodopentyloxy)phenyl)thiazolidine-2,4-dione

Conditions
ConditionsYield
Stage #1: 3-(4-hydroxyphenyl)-thiazolidine-2,4-dione With potassium carbonate In acetonitrile for 0.166667h; Schlenk technique;
Stage #2: 1,5-diiodopentane In acetonitrile at 95℃; for 7h; Schlenk technique;
88%
With potassium carbonate In acetonitrile at 95℃; for 7h; Schlenk technique;
1,5-diiodopentane
628-77-3

1,5-diiodopentane

allyl (6S,6aS)-6-((tert-butyldimethylsilyl)oxy)-3-hydroxy-2-methoxy-14-oxo-6,6a,7,12-tetrahydrobenzo[5,6][1,4]diazepino[1,2-b]isoquinoline-5(14H)-carboxylate

allyl (6S,6aS)-6-((tert-butyldimethylsilyl)oxy)-3-hydroxy-2-methoxy-14-oxo-6,6a,7,12-tetrahydrobenzo[5,6][1,4]diazepino[1,2-b]isoquinoline-5(14H)-carboxylate

C33H45IN2O6Si

C33H45IN2O6Si

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.666667h;88%
1,5-diiodopentane
628-77-3

1,5-diiodopentane

(S)-8-hydroxy-7-methoxy-1,2,3,11a-tetrahydro-5H-benzo[e]pyrrolo[1,2-a]azepin-5-one

(S)-8-hydroxy-7-methoxy-1,2,3,11a-tetrahydro-5H-benzo[e]pyrrolo[1,2-a]azepin-5-one

(S)-8-((5-hydroxypentyl)oxy)-7-methoxy-1,2,3,11a-tetrahydro-5H-benzo[e]pyrrolo[1,2-a]azepin-5-one

(S)-8-((5-hydroxypentyl)oxy)-7-methoxy-1,2,3,11a-tetrahydro-5H-benzo[e]pyrrolo[1,2-a]azepin-5-one

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 90℃; for 3h;87.6%

628-77-3Relevant articles and documents

Exploring the effect of chirality on the therapeutic potential of N-alkyl-deoxyiminosugars: anti-inflammatory response to Pseudomonas aeruginosa infections for application in CF lung disease

De Fenza, Maria,D'Alonzo, Daniele,Esposito, Anna,Munari, Silvia,Loberto, Nicoletta,Santangelo, Alessandra,Lampronti, Ilaria,Tamanini, Anna,Rossi, Alice,Ranucci, Serena,De Fino, Ida,Bragonzi, Alessandra,Aureli, Massimo,Bassi, Rosaria,Tironi, Matteo,Lippi, Giuseppe,Gambari, Roberto,Cabrini, Giulio,Palumbo, Giovanni,Dechecchi, Maria Cristina,Guaragna, Annalisa

supporting information, p. 63 - 71 (2019/05/10)

In the frame of a research program aimed to explore the relationship between chirality of iminosugars and their therapeutic potential, herein we report the synthesis of N-akyl L-deoxyiminosugars and the evaluation of the anti-inflammatory properties of selected candidates for the treatment of Pseudomonas aeruginosa infections in Cystic Fibrosis (CF)lung disease. Target glycomimetics were prepared by the shortest and most convenient approach reported to date, relying on the use of the well-known PS-TPP/I2 reagent system to prepare reactive alkoxyalkyl iodides, acting as key intermediates. Iminosugars ent-1-3 demonstrated to efficiently reduce the inflammatory response induced by P. aeruginosa in CuFi cells, either alone or in synergistic combination with their D-enantiomers, by selectively inhibiting NLGase. Surprisingly, the evaluation in murine models of lung disease showed that the amount of ent-1 required to reduce the recruitment of neutrophils was 40-fold lower than that of the corresponding D-enantiomer. The remarkably low dosage of the L-iminosugar, combined with its inability to act as inhibitor for most glycosidases, is expected to limit the onset of undesired effects, which are typically associated with the administration of its D-counterpart. Biological results herein obtained place ent-1 and congeners among the earliest examples of L-iminosugars acting as anti-inflammatory agents for therapeutic applications in Cystic Fibrosis.

Pheromone synthesis. Part 243: Synthesis and biological evaluation of (3R,13R,1′S)-1′-ethyl-2′-methylpropyl 3,13-dimethylpentadecanoate, the major component of the sex pheromone of Paulownia bagworm, Clania variegata, and its stereoisomers

Mori, Kenji,Tashiro, Takuya,Zhao, Boguang,Suckling, David M.,El-Sayed, Ashraf M.

experimental part, p. 2642 - 2653 (2010/05/18)

All of the four stereoisomers of (1′S)-1′-ethyl-2′-methylpropyl 3,13-dimethylpentadecanoate, the major component of the female sex pheromone of Clania variegata, were synthesized by employing olefin cross metathesis as the key reaction and starting from (R)- or (S)-2-methyl-1-butanol, (R)- or (S)-citronellal, and (S)-2-methyl-3-pentanol. Their bioassay revealed the (3R,13R,1′S)-isomer as the bioactive one, whose more efficient synthesis was achieved in two different ways by employing Wittig reaction as the key step.

Ring-Opening Iodo- and Bromosilation of Cyclic Ethers by Treatment with Iodo- and Bromotrialkylsilane Equivalents

Ohshita, Joji,Iwata, Arihiro,Kanetani, Fujio,Kunai, Atsutaka,Yamamoto, Yasushi,Matui, Chinami

, p. 8024 - 8026 (2007/10/03)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 628-77-3